Determinants of response of HER2+ gastric cancer (GC) vs gastroesophageal junction adenocarcinoma (GEJ) to margetuximab (M) plus pembrolizumab (P) post trastuzumab (T)

Park, H., Uronis, H., Kang, Y., Ng, M.C.H., Enzinger, P., Lee, K.W., Rutella, S. ORCID: 0000-0003-1970-7375, Church, S.E., Nordstrom, J., Knutson, K., Erskine, C., Wu, T., Yen, J., Franovic, A., Muth, J., Rosales, M., Vadakekolathu, J., Davidson-Moncada, J., Bang, Y. and Catenacci, D.V., 2019. Determinants of response of HER2+ gastric cancer (GC) vs gastroesophageal junction adenocarcinoma (GEJ) to margetuximab (M) plus pembrolizumab (P) post trastuzumab (T). Annals of Oncology, 30 (Supp5), v485. ISSN 0923-7534

Full text not available from this repository.
Item Type: Journal article
Publication Title: Annals of Oncology
Creators: Park, H., Uronis, H., Kang, Y., Ng, M.C.H., Enzinger, P., Lee, K.W., Rutella, S., Church, S.E., Nordstrom, J., Knutson, K., Erskine, C., Wu, T., Yen, J., Franovic, A., Muth, J., Rosales, M., Vadakekolathu, J., Davidson-Moncada, J., Bang, Y. and Catenacci, D.V.
Publisher: Elsevier
Date: October 2019
Volume: 30
Number: Supp5
ISSN: 0923-7534
Identifiers:
NumberType
10.1093/annonc/mdz253.015DOI
S0923753419594017Publisher Item Identifier
1280111Other
Divisions: Schools > School of Science and Technology
Depositing User: Linda Sullivan
Date Added: 30 Jan 2020 09:32
Last Modified: 30 Jan 2020 09:32
URI: http://irep.ntu.ac.uk/id/eprint/39124

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year